Abstract:Background: Inflammatory breast carcinoma (IBC) is an aggressive form of breast cancer associated with worse survival outcomes compared with other subtypes of breast cancer. Black patients with IBC have worse survival outcomes than White patients. Trimodality treatment (TMT) which includes neoadjuvant chemotherapy (NCT) followed by modified radical mastectomy without immediate reconstruction (MRM), and postmastectomy radiotherapy (PMRT), has been associated with improved survival outcomes for patients with IBC. Whether receipt of TMT varies by race, ethnicity, and insurance status and its impact on survival is largely unknown. Methods: Adult female patients with non-metastatic IBC treated from 2010-2018 were identified from the NCDB. Guideline concordant care (GCC) was defined as TMT administered in the correct sequence. In addition, clinical tumor/nodal stage, age, race, ethnicity, facility type, patient location, insurance status, and pathologic complete response (pCR) were examined for each patient. Additional quality metrics of GCC examined included time to initiation of NACT 6 lymph nodes removed) at the time of MRM without reconstruction. Univariate and multivariate mixed methods were performed to determine association between patient, treatment, and facility-level factors and receipt of GCC, TTNC < 60 days, and proper surgical care. OS was estimated using the Kaplan-Meier method, and the log-rank test was used to compare groups. Results: 7,374 women with non-metastatic IBC were included. 78% were White, 17% Black, and 2.5% Asian/Pacific Islander patients; 7.7% identified as Hispanic and 92% as non-Hispanic. The majority had private insurance (51%), 29% Medicare, 14% Medicaid, 4.9% uninsured, and 1.3% other government insurance.Only 2,418 patients (32.7%) received GCC with only 29% undergoing MRM without reconstruction.Receipt of GCC was more common among patients age >50 years, patients with higher clinical nodal burden and those treated from 2010-2013 (p=0.001).Receipt of GCC did not differ by race, ethnicity, insurance status, or location.92% (6,005/7,374 patients) received NAC within 60 days of diagnosis. Both Black (OR 0.58, 95% CI 0.46-0.74, p= < 0.001) and Asian (OR 0.52, 95% CI 0.30-0.90, p= < 0.001) patients with IBC were less likely to have TTNC < 60 days when compared to White patients. Non-Hispanic patients (OR 2.24, 95% CI 1.65-3.03, p= < 0.001) and those with private insurance (OR 1.82, 95% CI 1.23-2.68, p= < 0.001) were more likely to have TTNC within 60 days of diagnosis. Patients with lower clinical nodal burden(cN0) were less likely to undergo proper surgery compared to patients with higher nodal burden(cN1-3) (p < 0.001). In addition, patients treated in a more contemporary cohort (2014-2018) were less likely to undergo proper surgery compared to patients treated earlier (2010-2013) (OR 0.82, 95% CI 0.73-0.92, p< 0.001).Among IBC patients receiving GCC, Black patients had significantly worse overall survival compared to White patients (p < 0.001) Conclusions: The majority of patients with IBC do not receive GCC and GCC has decreased since 2014 with fewer patients undergoing appropriate surgical treatment. The very low level of GCC indicates a need for multidisciplinary education, while improvement in TTNC may improve outcomes among racial/ethnic minorities. Citation Format: Brian Diskin, Audree Tadros, Varadan Sevilimedu, Amy Xu, Perri Vingan, Jonas Nelson, Yoshiko Iwai, Monica Morrow, Oluwadamilola (Lola) Fayanju. Trends in Guideline Concordant Care for Inflammatory Breast Cancer: An analysis of the National Cancer Database [abstract]. In: Proceedings of the 2023 San Antonio Breast Cancer Symposium; 2023 Dec 5-9; San Antonio, TX. Philadelphia (PA): AACR; Cancer Res 2024;84(9 Suppl) nr PS18-07.

Receipt of guideline-concordant care and survival among young adult women with non-metastatic breast cancer

Receipt of Guideline-Concordant Care Is Associated With Improved Survival in Patients With Osteosarcoma in California: A Population-Based Analysis

The clinical features of breast cancer in young patients

Racial and elderly disparities in receipt of guideline-concordant care in stage I-III breast cancer.

Guideline-Consistent Treatment for Inflammatory Breast Cancer Provides Associated Survival Benefit Independent of Age

Abstract PS18-07: Trends in Guideline Concordant Care for Inflammatory Breast Cancer: An analysis of the National Cancer Database

Breast Cancer in Adolescent and Young Adult Women Under the Age of 40 Years.

Providing Survivorship Care for a Young Adult With a History of Blood Cancer

Clinical practice guidelines for adolescent and young adult cancer: A literature review.

The outcome of neoadjuvant chemotherapy and the current trend of surgical treatment in young women with breast cancer: A multicenter real-world study (CSBrS-012)

Abstract 1306: Preferences for survivorship care among AYA cancer survivors and challenges of cancer specialist-led follow up

Survival outcomes of young-age female patients with early breast cancer: an international multicenter cohort study

Association of commission on cancer accreditation with receipt of guideline‐concordant care and survival among patients with colon cancer

Breast Cancer in Young Women: Is It Different? A Single-Center Retrospective Cohort Study

Long-term health outcomes by cancer diagnosed age among adolescent and young adult: multinational representative database

Adolescent and young adult oncology—past, present, and future

Breast cancer survivorship among younger patients: challenges and opportunities-narrative review

Characteristics of Health Care Settings Where Adolescents and Young Adults Receive Care for ALL

Long-term oncologic outcomes following breast cancer surgery in adolescents and young adults: a single-center retrospective analysis

Comparison of Long-Term Oncological Results in Young Women with Breast Cancer between BRCA-Mutation Carriers Versus Non-Carriers: How Tumor and Genetic Risk Factors Influence the Clinical Prognosis

Abstract PO4-17-10: Epidemiological Analysis and Overall Survival of Female Adolescent and Young Adults Breast Cancer in a Developing Middle Eastern Country Over 18 Years